pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

STAT AI Prognosis newsletter tackles AI doomerism and offers guidance for health professionals

Sep 23, 2026·read at STAT ↗Neutral

The latest web edition of STAT’s AI Prognosis newsletter, authored by health tech reporter Brittany Trang, focuses on the growing chatter around AI doomerism. It aims to help readers cut through the hype and understand the implications for health care.

Trang notes that recent weeks have seen intense debate about whether artificial intelligence poses existential risks and whether its development should be slowed. The newsletter seeks to provide a balanced view for clinicians and industry observers.

The issue also encourages readers to share the content with colleagues and highlights a new essay by trust-in-science reporter Nick Florko, who writes about skepticism and misinformation in health treatments.

Overall, the newsletter positions itself as a practical guide for professionals navigating AI narratives in the medical field.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: AI doomerism: Here’s how to make sense of it”

read at STAT ↗
679 words · retrieved 52m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoSTAT+: Flagship gets a Pentagon contractSTAT
  • 2h agoSTAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and moreSTAT
  • 3h agoThe latest in the legal saga for youth gender-affirming care in the U.S.STAT
  • 6h agoSTAT+: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?STAT
  • 6h agoOpinion: Mentally ill women deserve more support to have childrenSTAT